Drug Type Small molecule drug |
Synonyms (+)-prednisolone hemisuccinate, Prednisolone 21-hemisuccinate, Prednisolone 21-succinate + [8] |
Target |
Mechanism GR agonists(Glucocorticoid receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (24 Dec 1960), |
Regulation- |
Molecular FormulaC25H32NaO8 |
InChIKeyBKKKAAMXMKMGER-CODXZCKSSA-N |
CAS Registry1715-33-9 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Mucocutaneous Lymph Node Syndrome | JP | 13 Sep 2013 | |
Adrenal Cortex Diseases | JP | 24 Dec 1960 | |
Ankylosing Spondylitis | JP | 24 Dec 1960 | |
Asthma | JP | 24 Dec 1960 | |
Collagen Diseases | JP | 24 Dec 1960 | |
Encephalomyelitis | JP | 24 Dec 1960 | |
Granulomatosis With Polyangiitis | JP | 24 Dec 1960 | |
Heart Failure | JP | 24 Dec 1960 | |
Juvenile Idiopathic Arthritis | JP | 24 Dec 1960 | |
Leukemia | JP | 24 Dec 1960 | |
Microscopic Polyangiitis | JP | 24 Dec 1960 | |
Multiple Sclerosis | JP | 24 Dec 1960 | |
Myasthenia Gravis | JP | 24 Dec 1960 | |
Polymyositis | JP | 24 Dec 1960 | |
Preeclamptic Toxemia | JP | 24 Dec 1960 | |
Pulmonary Fibrosis | JP | 24 Dec 1960 | |
Rheumatic Fever | JP | 24 Dec 1960 | |
Rheumatoid Arthritis | JP | 24 Dec 1960 | |
Systemic Lupus Erythematosus | JP | 24 Dec 1960 | |
Thyroiditis, Subacute | JP | 24 Dec 1960 |